StonvexLoading…
StonvexStonvexStonvexCore line items from MELI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $9.62B | $6.07B | $20.34B | $14.20B | $8.99B |
Operating Income | Not available | $611.00M | $3.20B | $2.31B | $1.59B |
Net Income | Not available | $417.00M | $2.00B | $1.44B | $523.00M |
EPS (Diluted) | $11.13 | $8.23 | $39.40 | $28.37 | $20.06 |
Total Assets | Not available | $46.93B | $42.67B | $36.69B | $32.95B |
Total Liabilities | Not available | $39.65B | $35.92B | $30.47B | $27.23B |
Cash & Equivalents | Not available | $3.68B | $3.67B | $2.58B | $3.01B |
Free Cash Flow OCF − CapEx | Not available | $1.80B | $10.77B | $5.99B | $3.39B |
Shares Outstanding | Not available | 50.70M | 50.70M | 50.70M | 50.70M |